Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.

PubWeight™: 2.76‹?› | Rank: Top 1%

🔗 View Article (PMC 3374131)

Published in Cell on June 26, 2009

Authors

Sujun Hua1, Ralf Kittler, Kevin P White

Author Affiliations

1: Institute for Genomics and Systems Biology and Department of Human Genetics, The University of Chicago, 920 East 58th Street, Chicago, IL 60637, USA.

Articles citing this

(truncated to the top 100)

A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol (2011) 16.53

ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res (2012) 9.13

Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol (2011) 3.33

Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell (2011) 2.97

A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell (2013) 2.58

Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev (2010) 2.06

Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci U S A (2011) 1.97

PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. PLoS Genet (2011) 1.93

Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res (2011) 1.92

Retinoids regulate stem cell differentiation. J Cell Physiol (2011) 1.91

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Cancer Discov (2011) 1.76

Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol (2010) 1.73

A comprehensive view of nuclear receptor cancer cistromes. Cancer Res (2011) 1.64

Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state. Mol Syst Biol (2011) 1.55

AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J (2011) 1.49

Vitamin A and retinoid signaling: genomic and nongenomic effects. J Lipid Res (2013) 1.43

Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res (2013) 1.30

Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Mol Cell Biol (2010) 1.30

Ligand-dependent dynamics of retinoic acid receptor binding during early neurogenesis. Genome Biol (2011) 1.19

Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. Mol Endocrinol (2010) 1.15

Enhancer activation requires trans-recruitment of a mega transcription factor complex. Cell (2014) 1.06

Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC. Blood (2009) 1.06

A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. Br J Cancer (2012) 1.05

Epigenetic regulation by RARα maintains ligand-independent transcriptional activity. Nucleic Acids Res (2011) 1.03

Discovering transcription factor regulatory targets using gene expression and binding data. Bioinformatics (2011) 1.02

Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements. Nucleic Acids Res (2010) 1.02

Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer. Hum Mol Genet (2011) 1.01

Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. J Biol Chem (2010) 1.01

Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. Genes Dev (2013) 1.00

Retinoic acid receptors recognize the mouse genome through binding elements with diverse spacing and topology. J Biol Chem (2012) 1.00

A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer. BMC Syst Biol (2011) 0.99

Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer. Nat Commun (2013) 0.99

Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2. PLoS Genet (2012) 0.99

Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses. Nucleic Acids Res (2013) 0.98

RARγ is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells. J Cell Sci (2012) 0.98

Novel mechanism of positive versus negative regulation by thyroid hormone receptor β1 (TRβ1) identified by genome-wide profiling of binding sites in mouse liver. J Biol Chem (2013) 0.98

Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels. Cell Metab (2014) 0.97

Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells. Am J Physiol Gastrointest Liver Physiol (2011) 0.97

Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium. Breast Cancer Res (2014) 0.97

A co-ordinated interaction between CTCF and ER in breast cancer cells. BMC Genomics (2011) 0.96

The transcription factor ultraspiracle influences honey bee social behavior and behavior-related gene expression. PLoS Genet (2012) 0.95

Genome-wide in silico identification of new conserved and functional retinoic acid receptor response elements (direct repeats separated by 5 bp). J Biol Chem (2011) 0.94

Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet. Cancer Res (2010) 0.94

Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells. Nucleic Acids Res (2013) 0.93

A role for gut-associated lymphoid tissue in shaping the human B cell repertoire. J Exp Med (2013) 0.91

During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein. Breast Cancer Res (2011) 0.91

Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells. Mol Endocrinol (2012) 0.89

Differential expression of genes involved in the epigenetic regulation of cell identity in normal human mammary cell commitment and differentiation. Chin J Cancer (2014) 0.89

3'LIFE: a functional assay to detect miRNA targets in high-throughput. Nucleic Acids Res (2014) 0.89

DNA recognition by thyroid hormone and retinoic acid receptors: 3,4,5 rule modified. Mol Cell Endocrinol (2009) 0.89

Spindle assembly checkpoint proteins regulate and monitor meiotic synapsis in C. elegans. J Cell Biol (2015) 0.89

Stromal retinoic acid receptor beta promotes mammary gland tumorigenesis. Proc Natl Acad Sci U S A (2010) 0.88

Far beyond the usual biomarkers in breast cancer: a review. J Cancer (2014) 0.87

Modular insulators: genome wide search for composite CTCF/thyroid hormone receptor binding sites. PLoS One (2010) 0.87

Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model. PLoS One (2013) 0.85

Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance. Nucleic Acids Res (2012) 0.85

Conformational Analysis of Free and Bound Retinoic Acid. J Chem Theory Comput (2012) 0.85

The potential of microRNAs in personalized medicine against cancers. Biomed Res Int (2014) 0.84

Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response. Proc Natl Acad Sci U S A (2011) 0.84

Genome-wide binding patterns of thyroid hormone receptor beta. PLoS One (2014) 0.84

The rhythm of retinoids in the brain. J Neurochem (2013) 0.84

Expanding the paradigm for estrogen receptor binding and transcriptional activation. Mol Endocrinol (2011) 0.83

Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation. EMBO J (2014) 0.83

Retinoic acid and cancer treatment. Biomedicine (Taipei) (2014) 0.82

Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression. EMBO Mol Med (2015) 0.82

Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology. Acta Pharmacol Sin (2014) 0.82

Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma. Br J Pharmacol (2014) 0.81

Retinoids and rexinoids in cancer prevention: from laboratory to clinic. Semin Oncol (2015) 0.81

Allele-specific down-regulation of RPTOR expression induced by retinoids contributes to climate adaptations. PLoS Genet (2010) 0.81

Systemic alteration of cell-surface and secreted glycoprotein expression in malignant breast cancer cell lines. Glycobiology (2013) 0.80

RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes. Mol Cancer (2014) 0.80

Chromatin immunoprecipitation: advancing analysis of nuclear hormone signaling. J Mol Endocrinol (2012) 0.80

Inference of RNA polymerase II transcription dynamics from chromatin immunoprecipitation time course data. PLoS Comput Biol (2014) 0.80

Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer. Oncotarget (2015) 0.80

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. Sci Adv (2016) 0.80

Cistrome plasticity and mechanisms of cistrome reprogramming. Cell Cycle (2012) 0.80

Noncommutative Biology: Sequential Regulation of Complex Networks. PLoS Comput Biol (2016) 0.79

Cooperating transcription factors mediate the function of estrogen receptor. Chromosoma (2012) 0.79

All trans-retinoic acid (ATRA) induces re-differentiation of early transformed breast epithelial cells. Int J Oncol (2014) 0.79

Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS. The role of Akt, IKKα, and DNA damage repair enzymes. Nucleus (2014) 0.78

Promoter-level expression clustering identifies time development of transcriptional regulatory cascades initiated by ErbB receptors in breast cancer cells. Sci Rep (2015) 0.78

Pan-cancer analyses of the nuclear receptor superfamily. Nucl Receptor Res (2015) 0.78

Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression. BMC Med Genomics (2013) 0.78

Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer. Cell Rep (2017) 0.77

Deciphering the divergent roles of progestogens in breast cancer. Nat Rev Cancer (2016) 0.77

RAR/RXR binding dynamics distinguish pluripotency from differentiation associated cis-regulatory elements. Nucleic Acids Res (2015) 0.77

Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer. Oncotarget (2016) 0.77

Vitamin D receptor and RXR in the post-genomic era. J Cell Physiol (2015) 0.76

Anti-tumor effects of a novel retinoic acid metabolism blocking agent VN/14-1 in the N-methyl-N-nitrosourea-induced rat mammary carcinoma model and its effects on the uterus. Breast Cancer Res Treat (2011) 0.76

Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. Oncogene (2016) 0.76

Cell-specific integration of nuclear receptor function at the genome. Wiley Interdiscip Rev Syst Biol Med (2013) 0.76

Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate. Oncotarget (2016) 0.76

Signalling Through Retinoic Acid Receptors is Required for Reprogramming of Both Mouse Embryonic Fibroblast Cells and Epiblast Stem Cells to Induced Pluripotent Stem Cells. Stem Cells (2015) 0.76

Transcriptome Analysis Revealed the Embryo-Induced Gene Expression Patterns in the Endometrium from Meishan and Yorkshire Pigs. Int J Mol Sci (2015) 0.76

Signaling through retinoic acid receptors in cardiac development: Doing the right things at the right times. Biochim Biophys Acta (2014) 0.76

Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation. PLoS One (2016) 0.75

Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1. Oncotarget (2016) 0.75

Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells. Oncotarget (2016) 0.75

RAI2: Linking Retinoic Acid Signaling with Metastasis Suppression. Cancer Discov (2015) 0.75

Phosphoproteome and Transcriptome of RA-Responsive and RA-Resistant Breast Cancer Cell Lines. PLoS One (2016) 0.75

Articles cited by this

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91

A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med (2002) 58.15

The steroid and thyroid hormone receptor superfamily. Science (1988) 25.68

Genomic maps and comparative analysis of histone modifications in human and mouse. Cell (2005) 18.96

Genome-wide analysis of estrogen receptor binding sites. Nat Genet (2006) 18.63

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell (2005) 14.32

FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell (2008) 14.18

The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics (2006) 12.45

The RXR heterodimers and orphan receptors. Cell (1995) 12.33

The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65

A decade of molecular biology of retinoic acid receptors. FASEB J (1996) 9.70

A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (1988) 9.07

A module map showing conditional activity of expression modules in cancer. Nat Genet (2004) 8.57

Identification of a receptor for the morphogen retinoic acid. Nature (1988) 8.32

BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals. Nat Methods (2008) 6.51

Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol (2006) 6.10

Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet (2007) 5.85

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol (2006) 4.84

Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell (2007) 4.66

The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell (1991) 4.27

From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A (2005) 4.16

Gene expression regulation by retinoic acid. J Lipid Res (2002) 3.62

Retinoic acid in development: towards an integrated view. Nat Rev Genet (2008) 3.24

RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov (2007) 3.07

Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development (1994) 2.98

Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res (2007) 2.95

Transcriptional repression by nuclear hormone receptors. Trends Endocrinol Metab (2001) 2.24

MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res (1997) 2.12

Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene (2003) 2.02

About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer. Mol Cell Endocrinol (2004) 1.97

Retinoic acid receptors and cancers. Annu Rev Nutr (2004) 1.93

Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol (2008) 1.89

GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol (2008) 1.68

Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. J Proteome Res (2006) 1.66

Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc Natl Acad Sci U S A (2008) 1.64

Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling. Cancer Res (2005) 1.38

Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer Res (2007) 1.38

Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells. J Biol Chem (1998) 1.17

Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro. Oncogene (1997) 0.98

In vitro and in vivo interactions between nuclear receptors at estrogen response elements. J Steroid Biochem Mol Biol (1996) 0.84

Articles by these authors

Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science (2010) 12.39

Unlocking the secrets of the genome. Nature (2009) 11.80

Gene expression during the life cycle of Drosophila melanogaster. Science (2002) 11.36

ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res (2012) 9.13

Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. Genome Res (2005) 8.38

Evolution of gene expression in the Drosophila melanogaster subgroup. Nat Genet (2003) 6.60

BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals. Nat Methods (2008) 6.51

A gene expression map for the euchromatic genome of Drosophila melanogaster. Science (2004) 5.38

A cis-regulatory map of the Drosophila genome. Nature (2011) 4.80

Expression profiling in primates reveals a rapid evolution of human transcription factors. Nature (2006) 4.26

Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A (2011) 3.80

A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell (2009) 3.55

Identification of genes involved in Drosophila melanogaster geotaxis, a complex behavioral trait. Nat Genet (2002) 3.53

Chromosomal distribution of PcG proteins during Drosophila development. PLoS Biol (2006) 3.41

Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A (2014) 3.35

Versatile P[acman] BAC libraries for transgenesis studies in Drosophila melanogaster. Nat Methods (2009) 3.35

A comprehensive map of insulator elements for the Drosophila genome. PLoS Genet (2010) 3.25

Multi-species microarrays reveal the effect of sequence divergence on gene expression profiles. Genome Res (2005) 3.23

Hotspots of transcription factor colocalization in the genome of Drosophila melanogaster. Proc Natl Acad Sci U S A (2006) 3.06

HAUS, the 8-subunit human Augmin complex, regulates centrosome and spindle integrity. Curr Biol (2009) 2.98

Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Mol Cell (2009) 2.84

Immune signaling pathways regulating bacterial and malaria parasite infection of the mosquito Anopheles gambiae. Proc Natl Acad Sci U S A (2005) 2.81

Tissue-specific gene expression and ecdysone-regulated genomic networks in Drosophila. Dev Cell (2003) 2.63

Genome expression analysis of Anopheles gambiae: responses to injury, bacterial challenge, and malaria infection. Proc Natl Acad Sci U S A (2002) 2.59

CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood (2012) 2.51

Duplicate genes increase gene expression diversity within and between species. Nat Genet (2004) 2.40

Systematic evaluation of factors influencing ChIP-seq fidelity. Nat Methods (2012) 2.31

Adaptive evolution and the birth of CTCF binding sites in the Drosophila genome. PLoS Biol (2012) 2.29

A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell (2013) 2.28

Parallel on-chip gene synthesis and application to optimization of protein expression. Nat Biotechnol (2011) 2.22

A mutation accumulation assay reveals a broad capacity for rapid evolution of gene expression. Nature (2005) 2.08

A comprehensive survey of human Y-chromosomal microsatellites. Am J Hum Genet (2004) 1.97

Control of mitochondrial structure and function by the Yorkie/YAP oncogenic pathway. Genes Dev (2012) 1.97

Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol (2008) 1.89

The mammalian SPD-2 ortholog Cep192 regulates centrosome biogenesis. Curr Biol (2008) 1.88

RNA-seq differential expression studies: more sequence or more replication? Bioinformatics (2013) 1.87

Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer. Science (2009) 1.83

Evaluation of saliva as a source of human DNA for population and association studies. Anal Biochem (2006) 1.81

ChIP-chip versus ChIP-seq: lessons for experimental design and data analysis. BMC Genomics (2011) 1.80

Microparadigms: chains of collective reasoning in publications about molecular interactions. Proc Natl Acad Sci U S A (2006) 1.68

Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J Virol (2004) 1.61

Evidence of abundant stop codon readthrough in Drosophila and other metazoa. Genome Res (2011) 1.60

Identification of tightly regulated groups of genes during Drosophila melanogaster embryogenesis. Mol Syst Biol (2007) 1.53

Comparative profiling identifies C13orf3 as a component of the Ska complex required for mammalian cell division. EMBO J (2009) 1.51

Protein-DNA interaction mapping using genomic tiling path microarrays in Drosophila. Proc Natl Acad Sci U S A (2003) 1.46

Long-lived Indy induces reduced mitochondrial reactive oxygen species production and oxidative damage. Proc Natl Acad Sci U S A (2009) 1.42

Experimental selection for Drosophila survival in extremely low O(2) environment. PLoS One (2007) 1.40

Juvenile hormone and its receptor, methoprene-tolerant, control the dynamics of mosquito gene expression. Proc Natl Acad Sci U S A (2013) 1.39

Detecting transcriptionally active regions using genomic tiling arrays. Genome Biol (2006) 1.37

Mechanisms underlying hypoxia tolerance in Drosophila melanogaster: hairy as a metabolic switch. PLoS Genet (2008) 1.36

Verrucous porokeratosis of the gluteal cleft (porokeratosis ptychotropica): a rare disorder easily misdiagnosed. J Cutan Pathol (2009) 1.35

Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis. Blood (2012) 1.35

Analysis of the eye developmental pathway in Drosophila using DNA microarrays. Proc Natl Acad Sci U S A (2003) 1.31

Genomic mapping of binding regions for the Ecdysone receptor protein complex. Genome Res (2009) 1.24

Genome-wide tissue-specific occupancy of the Hox protein Ultrabithorax and Hox cofactor Homothorax in Drosophila. PLoS One (2011) 1.23

Genome-wide association of Yorkie with chromatin and chromatin-remodeling complexes. Cell Rep (2013) 1.19

Consequences of eukaryotic enhancer architecture for gene expression dynamics, development, and fitness. PLoS Genet (2011) 1.13

A comprehensive nuclear receptor network for breast cancer cells. Cell Rep (2013) 1.09

CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells. Cancer Res (2011) 1.06

Recombinant antibodies to histone post-translational modifications. Nat Methods (2013) 1.05

Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. Proc Natl Acad Sci U S A (2014) 1.04

HOT1 is a mammalian direct telomere repeat-binding protein contributing to telomerase recruitment. EMBO J (2013) 1.04

Discovering transcription factor regulatory targets using gene expression and binding data. Bioinformatics (2011) 1.02

Developmental genomic approaches in model organisms. Annu Rev Genomics Hum Genet (2002) 1.01

Enhanced function annotations for Drosophila serine proteases: a case study for systematic annotation of multi-member gene families. Gene (2007) 0.99

Probabilistic inference of molecular networks from noisy data sources. Bioinformatics (2004) 0.98

Enzymatically prepared RNAi libraries. Nat Methods (2006) 0.98

The transcription factor ultraspiracle influences honey bee social behavior and behavior-related gene expression. PLoS Genet (2012) 0.95

The relationship between long-range chromatin occupancy and polymerization of the Drosophila ETS family transcriptional repressor Yan. Genetics (2012) 0.94

Determinants of antigenicity and specificity in immune response for protein sequences. BMC Bioinformatics (2011) 0.94

Reshaping of global gene expression networks and sex-biased gene expression by integration of a young gene. EMBO J (2012) 0.94

Genetic pathways leading to therapy-related myeloid neoplasms. Mediterr J Hematol Infect Dis (2011) 0.93

Tissue-specific RNA interference in post-implantation mouse embryos using directional electroporation and whole embryo culture. Differentiation (2004) 0.93

Fatal pancreatitis presenting as pancreatic panniculitis without enzyme elevation. J Cutan Pathol (2011) 0.91

Low-grade prostate cancer diverges early from high grade and metastatic disease. Cancer Sci (2014) 0.90

A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult. Hum Mol Genet (2012) 0.87

Frequent recent origination of brain genes shaped the evolution of foraging behavior in Drosophila. Cell Rep (2012) 0.87

Genome sequences of the primary endosymbiont "Candidatus Portiera aleyrodidarum" in the whitefly Bemisia tabaci B and Q biotypes. J Bacteriol (2012) 0.86

Evidence for autoregulation and cell signaling pathway regulation from genome-wide binding of the Drosophila retinoblastoma protein. G3 (Bethesda) (2012) 0.86

Multicentric reticulohistiocytosis and urologic carcinomas: a possible paraneoplastic association. J Cutan Pathol (2010) 0.85

Developmental stage and level of codon usage bias in Drosophila. Mol Biol Evol (2008) 0.85

Recent advances in Drosophila genomics. Genome Biol (2004) 0.84

Genome-wide analyses of Shavenbaby target genes reveals distinct features of enhancer organization. Genome Biol (2013) 0.84

The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q). Br J Haematol (2014) 0.84

Divergent transcriptional regulatory logic at the intersection of tissue growth and developmental patterning. PLoS Genet (2013) 0.83

Comparison of the genome sequences of "Candidatus Portiera aleyrodidarum" primary endosymbionts of the whitefly Bemisia tabaci B and Q biotypes. Appl Environ Microbiol (2013) 0.83

Person-centered approach to care, teaching, and research in fibromyalgia syndrome: justification from biopsychosocial perspectives in populations. Semin Arthritis Rheum (2002) 0.83

The relationship between cognitive appraisal, affect, and catastrophizing in patients with chronic pain. J Pain (2003) 0.82

Allele-specific down-regulation of RPTOR expression induced by retinoids contributes to climate adaptations. PLoS Genet (2010) 0.81

Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer. Proc Natl Acad Sci U S A (2012) 0.81

Ultrabithorax confers spatial identity in a context-specific manner in the Drosophila postembryonic ventral nervous system. Neural Dev (2012) 0.80

Primary scrotal melanoma presenting as a large, amelanotic, exophytic mass. Arch Dermatol (2009) 0.80

Interpreting the regulatory genome: the genomics of transcription factor function in Drosophila melanogaster. Brief Funct Genomics (2012) 0.79

Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma. Am J Surg Pathol (2011) 0.79

A novel mechanism of inherited TBG deficiency: mutation in a liver-specific enhancer. J Clin Endocrinol Metab (2015) 0.79

An integrated genomic approach to the assessment and treatment of acute myeloid leukemia. Semin Oncol (2011) 0.79

Systematic mapping of occluded genes by cell fusion reveals prevalence and stability of cis-mediated silencing in somatic cells. Genome Res (2013) 0.79

The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling. Hum Pathol (2013) 0.78